IMVT

IMVT Operating Income Growth

-18.64%TTM

Period ending:

IMVT TTM Operating Income YoY %%
IMVT TTM Operating Income YoY %70.66%-852.09%
2020-03-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

IMVT operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 26 observations from Mar 31, 2020 to Jun 30, 2026.

Immunovant Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-18.64%
-21.6252%
-20.2288%
-38.2053%
-57.8136%
-62.1526%
-59.7881%
-43.2381%
-27.6367%
-29.7366%
-32.6004%
-37.8605%
-40.4473%
-33.4805%
-38.8596%
-39.3417%
-49.4592%
-44.3196%
-38.162%
-61.9708%
-90.3596%
-237.4849%
-762.7912%
-741.5943%
-284.6319%
-64.3457%

Compare operating income growth

All IMVT financial metrics · IMVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.